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Pure choriocarcinoma is very rare in the testes, and host
immune responses including tumor infiltrating lymphocytes
are unusual in choriocarcinoma. This study reports a case of
pure testicular choriocarcinoma with extensive lymphocytic in-
filtrate and granulomatous inflammation. Scrotal ultrasono-
graphy revealed a heterogeneous, hyperechoic intratesticular
mass. -human chorionic gonadotropin levels were elevated in β
a radioimmunoassay. The hemorrhagic and necrotic solid mass
was composed of two cell populations - mononuclear pleomor-
phic cells and intimately admixed multinucleated smudged
cells. The tumor cells were positive for cytokeratin 7, epider-
mal growth factor receptors, human placental lactogen and
p57. Many inflammatory cells were present within the tumor.
The majority of infiltrating cells were CD8-positive cytotoxic
cells, which also expressed granzyme-B and TIA-1. The tumor
cells were positive for FasL, but negative for Fas. Therefore,
this case seemed to escape the host defense response to the
tumor due to the loss of Fas, although the cellular host immune
response was still active.
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INTRODUCTION
Pure choriocarcinoma in the testes is very rare,
representing less than 1% (0.19%) of testicular
germ cell tumors; however, it is admixed with
other germ cell tumor elements in 8% of testicular
germ cell tumors.
1 Seminoma is typically asso-
ciated with prominent lymphocytic infiltrate and
an excellent prognosis.
2,3 However, such host im-
mune responses are unusual and have not been
well defined in choriocarcinoma. Here, we de-
scribe a case of pure testicular choriocarcinoma
with extensive lymphocytic infiltrate and granulo-
matous inflammation.
CASE REPORT
A 28-year-old man was admitted with com-
plaints of right scrotal discomfort for a period of
3 weeks. A physical examination revealed a non-
tender, movable hard mass on the right testis.
Scrotal ultrasonography revealed a heterogeneous,
hyperechoic intratesticular mass, suggesting a ma-
lignant germ cell tumor. The -human chorionic β
gonadotropin level was elevated (4.743, normal
range: 0-0.01 IU/mL), and -fetoprotein levels α were
normal (2.03, normal range: 0-15 ng/mL) in the ra-
dioimmunoassay. A right orchiectomy was done.
Upon gross examination, the testis was 5.5 × 4
cm in size and was nearly replaced by a hemor-
rhagic and necrotic solid mass (Fig. 1A). Histolo-
gically, the tumor showed extensive hemorrhage
and necrosis. Viable tumor cells were generally
present in the periphery of the hemorrhagic and
necrotic areas. The tumor was composed of two
cell populations - mononuclear pleomorphic cells
and intimately admixed multinucleated smudged
cells (Fig. 1B). The tumor cells were diffusely posi-
tive for pan-cytokeratin, cytokeratin 7, and epider-
mal growth factor receptors and focally positive
for human placental lactogen, p57 (Fig. 1C), pla-
cental alkaline phosphatase, epithelial membrane
antigens, carcinoembryonic antigens and negative
for vimentin, -fetoprotein, c-kit and CD30. Pecu α -
liarly, many inflammatory cells were present in
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Fig. 2. Several inflammatory cells were present within the tumor nests (A). Loose aggregates of epithelioid histiocytes
forming granulomas were also noted (B). The infiltrating cells were mostly CD8-positive cytotoxic T-cells (C), which also
expressed TIA-1 (D).
Fig. 1. Upon gross examination, the testis was 5.5 × 4 cm in size and was nearly replaced by a hemorrhagic and necrotic
solid mass (A). Histologically, the tumor was composed of two cell populations-mononuclear pleomorphic cells and
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the connective tissue between tumor nodules and
within tumor nests (Fig. 2A). These cells were
mostly CD3-positive T-lymphocytes and CD68-
positive histiocytes. Many plasma cells were also
admixed. Most of the T-cells were CD8-positive
cytotoxic cells (Fig. 2C), which also expressed
granzyme-B and TIA-1 (Fig. 2D). Occasionally,
loose aggregates of epithelioid histiocytes forming
granulomas were noted (Fig. 2B). The immuno-
stainings of Fas and FasL showed that the tumor
cells were diffusely positive for FasL (Fig. 1D), but
negative for Fas. In contrast, infiltrating lympho-
cytes were strongly positive for both Fas and
FasL.
Postoperative abdominopelvic computed tomo-
graphy showed multiple lymph node enlarge-
ments in both the inguinal and common iliac
areas and in the left paraaortic area. The patient
received three cycles of chemotherapy with BEP
(Bleomycin, Etoposide, Cisplatin) and is well at
present, 6 months after surgery. Lymph nodes
enlargements were not changed.
DISCUSSION
There is a wide range of patterns of cellular
immune response to different histological tumor
types. The immunocompetent cells that infiltrate
tumors are mostly T-lymphocytes and macro-
phages, with a few B-lymphocytes and very few
NK-cells.
4 The number and type of tumor-infil-
trating lymphocytes (TIL) have been reported to
be significant determinants of outcome in a
variety of malignancies, including non-Hodgkin's
lymphoma, esophageal carcinoma, malignant mel-
anoma, colorectal carcinoma, and breast cancer.
2
An active host immune response is considered to
inhibit tumor growth and metastasis.
2
In testicular germ cell tumors, seminoma is
typically associated with prominent lymphocytic
infiltrate and an excellent prognosis.
2,3 Intense
infiltrates of immunocompetent cells are present
within the connective tissue surrounding the
tumor lobules, with frequent individual lym-
phocytes within the tumor itself.
2 TIL in semino-
ma are predominantly T-cells with primarily a
CD8+ phenotype.
5 B-cells tend to accumulate and
occasionally form lymphoid follicles with a
phenotypic pattern of B-cell antigens that is com-
parable to secondary lymphoid follicles.
5 This
suggests both the functional maturation of B-cells
and a cytotoxic T response. Most cytotoxic T-
lymphocytes (CTL) infiltrating seminoma tumor
nests express immunohistochemical markers of
cytotoxic potential and activity, i.e. TIA-1 and
granzyme B.
3 A significant proportion of apoptotic
seminomatous tumor cells are in direct contact
with CD3+ and granzyme B+ cells, and a number
of activated CTLs show a strong linear correlation
with the apoptotic index in seminoma,
3 suggesting
that apoptotic tumor cell death may be triggered
by cytotoxic granule effectors.
3 In a study of tes-
ticular seminomas, a lower TIL count was asso-
ciated with a significantly increased risk of relapse
according to univariate analysis.
2 These results
suggest that the activity of the antitumor host
immune response is a determinant of outcome,
which may result from apoptotic tumor cell death
by CTL
2,3 and lead to speculation about a potential
role for immunotherapeutic strategies in this
tumor type.
2 Similar lymphoid infiltrate is only
rarely observed in non-seminomatous germ cell
tumors, including choriocarcinoma.
3
Choriocarcinoma is a malignant tumor of the
trophoblast. In normal placentation, trophoblasts
show “controlled invasion” at the placental site as
part of the normal process of implantation,
6
without being rejected and without destroying the
tissue.
7 It is noteworthy that the trophoblast nor-
mally behaves in a manner that is interpreted as
indicative of malignancy. Therefore, choriocarci-
noma is unique in that it represents a malignant
transformation of a tissue that inherently has
invasive and metastatic properties.
6
Immunocompetent cells, which are known to be
involved in the rejection pathways of malignant
cells, can also be identified in early pregnancy
decidua. In choriocarcinoma, a significantly in-
creased number of lymphocytes that are positive
for CD8, CD3 and mast cell tryptase positive
granulocytes have been observed in comparison
with the samples from normal pregnancy, but
lymphocytes positive for natural killer cell marker
CD56 are significantly decreased in choriocar-
cinoma, which suggests the necessity of a balance
between T and NK cells in controlling trophoblast
invasion.
7 The expression of MHC class I mole-Jai Hyang Go
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cules is required by professional antigen-pre-
senting cells or neoplastic cells for specific CTL
activation,
3 and human trophoblast and choriocar-
cinoma cell lines express a truncated HLA class I
molecule
8 which can initiate a cell-mediated im-
mune response. Cell-mediated immunity to
trophoblast antigens was also noted in women
with recurrent spontaneous abortion in vitro.
9
In contrast, choriocarcinoma cells can induce
immunosuppression by down-regulation of inter-
leukin-2, the interleukin-2 receptor alpha chain,
and its Jak/Stat signaling pathway, which might
play a key role in the expression of choriocarci-
noma, as well as in the survival of the fetal allo-
graft.
10 Choriocarcinoma cell culture supernatant
suppresses lymphocyte activity, which is demon-
strated by decreased surface activation of classical
activation markers such as CD25, CD69, CD71,
CD134, and CD3/HLA-DR.
11
In the present case, many TIA-positive, granzyme
B-positive cytotoxic T-cells infiltrated the tumor
nodules of choriocarcinoma, which suggests that
the immunosuppressive activity of choriocar-
cinoma cells is limited and that the cell-mediated
immune reaction to trophoblast antigens is still
active in this tumor. Many histiocytes which
occasionally formed granulomas were also found
within the tumor. During malignancies, the im-
mune escape of tumor cells and successful tumor
outgrowth may be attributed to the inability of the
immune system to react to the tumor.
6
In addition to cytotoxic granule release, CTL-
triggered apoptosis may be mediated by the
Fas/Fas ligand (FasL) pathway.
3 There is now
adequate evidence indicating that the suscep-
tibility of tumor cells to Fas-mediated apoptosis is
largely reduced through the aberrant loss of Fas.
6
FasL expression under physiological conditions is
frequently limited, and FasL is expressed more
frequently in malignant cells when compared with
their non-malignant counterparts.
6 Aberrant FasL
expression by tumors has been implicated in the
abrogation of the host antitumor response by
killing of Fas-positive effector lymphocytes,
6 and
this ligand could have a significant role in local
tissue destruction, metastatic spread, and immune
escape of tumor cells.
6
Although the expression of Fas or FasL in
testicular seminoma is controversial,
3 human cho-
riocarcinoma cells are known to co-express Fas
and FasL.
6 Fas receptors are down-regulated when
compared to a Fas-sensitive cell line. Therefore, it
is possible that choriocarcinoma evades immune
attack by down-regulation of Fas receptors and by
killing lymphocytes through the expression of
FasL.
6 The Fas/FasL system may represent a
mechanism by which malignant trophoblasts
become resistant to apoptosis, escape immune sur-
veillance, and metastasize,
6,12 resulting in the clini-
cal sequelae characteristic of choriocarcinoma.
6 In
the present case, the tumor cells were diffusely
positive for FasL, but negative for Fas, in contrast
to infiltrating lymphocytes which were strongly
positive for both Fas and FasL. Therefore, we
speculate that the present case would be biolo-
gically aggressive in spite of the active cell-medi-
ated immune reaction. Because restoring the
apoptotic potential of cancer cells in modulating
the expression and activity of certain key compo-
nents of the cell death machinery could be an
attractive strategy for therapeutic intervention in
the management of choriocarcinoma,
6 such therapy
might be useful for this particular case.
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